Single Maintenance And Reliever Therapy Pathway
GPTKB entity
Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:medical_treatment_protocol
|
| gptkbp:alternativeName |
SMART pathway
|
| gptkbp:appliesTo |
patients with moderate to severe asthma
|
| gptkbp:benefit |
reduces need for oral corticosteroids
simplifies asthma treatment regimen |
| gptkbp:goal |
improve asthma control
reduce asthma exacerbations |
| gptkbp:involves |
use of inhaled corticosteroid and long-acting beta-agonist combination
|
| gptkbp:medicationExample |
gptkb:budesonide/formoterol
beclometasone/formoterol |
| gptkbp:method |
uses same inhaler for both maintenance and relief
|
| gptkbp:recommendation |
gptkb:Global_Initiative_for_Asthma
|
| gptkbp:usedFor |
asthma management
|
| gptkbp:bfsParent |
gptkb:SMART_Pathway
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Single Maintenance And Reliever Therapy Pathway
|